Title
Men Who Have Sex With Men in Peru: Acceptability of Medication-Assisted Therapy for Treating Alcohol Use Disorders
Date Issued
01 July 2017
Access level
open access
Resource Type
journal article
Author(s)
Brown S.E.
Vagenas P.
Clark J.L.
Sanchez J.
Duerr A.C.
Altice F.L.
David Geffen School of Medicine at UCLA
Publisher(s)
SAGE Publications Inc.
Abstract
In Peru, the HIV epidemic is concentrated in men who have sex with men (MSM) and transgender women (TGW). Multiple studies correlate alcohol use disorders (AUDs) with risky sexual behaviors among Peruvian MSM. Qualitative research was used to inform a clinical trial on the acceptability of medication-assisted therapies to assist management of AUDs and improve antiretroviral therapy (ART) adherence among MSM/TGW in Peru. Three focus groups involving HIV-infected or HIV-uninfected MSM/TGW (n = 26) with AUDs (AUDIT ≥ 8) were transcribed, translated from Spanish into English, and analyzed using thematic content analysis. Despite having an AUD, participants considered themselves “social” drinkers, minimized their drinking behaviors, and differed about whether or not alcohol problems could be treated. Participants expressed skepticism about medication for treating AUDs. Three concepts emerged as necessary components of a treatment program for alcohol problems: cost, family support, and the potential to drink less alcohol without attaining total abstinence. This study reveals important areas of education to increase potential acceptability of a medication for treating AUDs among MSM/TGW. Given the social conditions and knowledge base of the participants, medication-assisted therapies using naltrexone may be a beneficial strategy for MSM with AUDs.
Start page
1269
End page
1278
Volume
11
Issue
4
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Abuso de sustancias
Subjects
Scopus EID
2-s2.0-85021119172
PubMed ID
Source
American Journal of Men's Health
ISSN of the container
15579883
Sponsor(s)
National Institute of Mental Health K23MH084611, P30MH058107
National Institute on Drug Abuse K24DA017072, R01DA030762, R01DA030768, R01DA032106
National Center for Advancing Translational Sciences UL1TR001863
Sources of information:
Directorio de Producción Científica
Scopus